Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misoprostol dosing for labor induction in obese women
NCT05262738Phase 4Completed
- Sponsor
- University of Texas at Austin
- Start
- Jun 2022
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of misoprostol in dystocia, sponsored by University of Texas at Austin. Primary endpoint: Interval Time From Labor Induction Initiation to Delivery (Vaginal or Cesarean) at 3 days. Started Jun 2022; status: completed.
02
Drugs
misoprostol
03
Conditions
dystocia
Beyond the preview
Go deeper on NCT05262738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05262738.